When Randomized Clinical Trials and Real‐World Evidence Say the Same: Tocilizumab and Its Cardiovascular Safety
Year: 2019
Type: editorial
Source: Arthritis & Rheumatology
DOI: 10.1002/art.41092
Authors: Seoyoung C. Kim, Sebastian Schneeweiss
Institutions: Brigham and Women's Hospital, Harvard University
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2970895860
